Physician profile
Cameron M Charchenko
NPI 1750676201
$1,559.86
in general payments reported to CMS, 2019-2025
11 companies · $265 in 2025
The $265 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.50 · 2021: $358 · 2022: $261 · 2023: $321 · 2024: $283 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $643 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $125 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.27 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $124.99 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $622.22 | 2021-2024 | Isiris Astent Removal Device, Coloplast Tfl Drive, Stenostent |
| Intuitive Surgical, INC. | $179.72 | 2021-2023 | Da Vinci Surgical System |
| C. R. Bard, INC. & Subsidiaries | $157.55 | 2025 | Aptra, Bard X-Force Balloon Dilation Catheter |
| Sumitomo Pharma America, INC. | $124.99 | 2024 | Orgovyx |
| Myovant Sciences INC. | $109.28 | 2021 | |
| Astellas Pharma US INC | $99.99 | 2023 | |
| Urogen Pharma, INC. | $91.87 | 2025 | |
| Janssen Biotech, INC. | $72.50 | 2019 | |
| Procept Biorobotics Corporation | $53.06 | 2022 | |
| Olympus America INC. | $33.33 | 2021 | |
| Pfizer INC. | $15.35 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Charchenko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.